| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/09/1994 | WO1994012162A1 Syndecan stimulation of cellular differentiation |
| 06/09/1994 | WO1994008949A3 Metal-oxime chelates for use as radiopharmaceutical agents |
| 06/09/1994 | WO1994004541A3 Protein kinase inhibitors and related compounds combined with taxol |
| 06/09/1994 | WO1994004180A3 Novel uses of il-4 and/or il-10, and antibodies against the same |
| 06/09/1994 | CA2150946A1 Treatment of dermatological malignancies with biologically active peptides |
| 06/09/1994 | CA2149883A1 Cellular genes encoding retinoblastoma-associated proteins |
| 06/09/1994 | CA2149882A1 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
| 06/09/1994 | CA2149758A1 New process for preparing taxane derivatives; new derivatives thus obtained and compositions containing them |
| 06/09/1994 | CA2149640A1 Carboxy-peptidyl derivatives as antidegenerative active agents |
| 06/09/1994 | CA2149635A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
| 06/08/1994 | EP0600831A1 Phtalazinon derivatives |
| 06/08/1994 | EP0600830A1 Substituted derivatives of diaminophthalimide as protein-tyrosine kinase inhibitors |
| 06/08/1994 | EP0600745A1 The elucidation and synthesis of antineoplastic tetrapeptide phenethylamides of dolastatin 10 |
| 06/08/1994 | EP0600744A1 Tumor inhibiting tetrapeptide bearing modified phenethyl amides |
| 06/08/1994 | EP0600591A2 Inhibition of tumor cell growth by administration of B7-transfected cells |
| 06/08/1994 | EP0600544A1 Use of lycopene for reducing the activity of cells, especially of cancer cells, and pharmaceutical preparations |
| 06/08/1994 | EP0600517A1 6,7-Modified paclitaxels |
| 06/08/1994 | EP0600062A1 Polymer-bound paclitaxel derivatives |
| 06/08/1994 | EP0600028A1 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones |
| 06/08/1994 | EP0600026A1 Cardiac output probe assembly |
| 06/08/1994 | EP0599881A1 Gallium (iii) complexes, process for their obtention and pharmaceutical compositions containing them |
| 06/08/1994 | EP0531300B1 Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy |
| 06/08/1994 | EP0517789B1 Inhibitor of proliferation of endothelial cells |
| 06/08/1994 | CN1087639A Heterotricyclic derivatives |
| 06/08/1994 | CN1087637A Water soluble camptothecin analogs |
| 06/08/1994 | CN1024922C Morpholinyl derivatives of doxorubicin and process for their prepn. |
| 06/07/1994 | US5319097 Pharmaceutical agents |
| 06/07/1994 | US5318994 N-[2-(7-lower-alkoxynaphth-1-yl)ethyl]benzamides |
| 06/07/1994 | US5318965 Administering to treat leukemia, melanoma, carcinoma of lung, colon, ovaries |
| 06/07/1994 | US5318964 Hydroxamic derivatives and pharmaceutical compositions |
| 06/07/1994 | CA1330039C Compounds having anti-progestational and anti-estrogenic activities for the treatment of hormone-dependent tumors |
| 06/07/1994 | CA1330037C Treatment of cancer with somatostatin and analogs thereof |
| 06/07/1994 | CA1330035C Pharmaceutical combination preparations for use in anti-neoplastic therapy |
| 06/05/1994 | CA2110117A1 Hispidospermidin |
| 06/01/1994 | EP0599514A2 Pyranoquinoline derivatives as inhibitors of cell proliferation |
| 06/01/1994 | EP0598770A1 New pyrazine derivatives, their preparation and their use. |
| 06/01/1994 | EP0354917B1 Method of prolonging cancerous patient survival in humans with hydrazine sulfate |
| 05/31/1994 | US5316920 Lymphocyte activation antigen HB15, a member of the immunoglobulin superfamily |
| 05/31/1994 | US5316763 Antitumor |
| 05/31/1994 | CA2109750A1 Method and pharmaceutical preparations for reducing the activity of cells |
| 05/31/1994 | CA1329932C Acyl deoxyribonucleoside derivatives and uses thereof |
| 05/28/1994 | CA2109993A1 Substituted derivatives of diaminophthalimide |
| 05/28/1994 | CA2109992A1 Phthalazinone derivatives |
| 05/26/1994 | WO1994011738A1 Determination of peptide motifs on mhc molecules |
| 05/26/1994 | WO1994011547A1 Process for the preparation of taxane derivatives, novel taxanes so obtained and antitumour and antileukaemia compositions containing same |
| 05/26/1994 | WO1994011535A1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy |
| 05/26/1994 | WO1994011522A2 Vector for the expression of therapy-relevant genes |
| 05/26/1994 | WO1994011513A1 Heat shock proteins and the treatment of tumours |
| 05/26/1994 | WO1994011509A2 Peptides and anti-sense peptides with broad neoplastic specificity |
| 05/26/1994 | WO1994011502A2 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
| 05/26/1994 | WO1994011499A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 05/26/1994 | WO1994011394A2 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 05/26/1994 | WO1994011385A1 17-alpha-acyl steroids which inhibit 5-alpha-reductase |
| 05/26/1994 | WO1994011381A1 Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides |
| 05/26/1994 | WO1994011377A2 Water soluble camptothecin derivatives |
| 05/26/1994 | WO1994011362A1 Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them |
| 05/26/1994 | WO1994011354A1 Tricyclic compounds with pharmaceutical activity |
| 05/26/1994 | WO1994011338A1 Use of n-arylmethylene, ethylenediaminetriacetates n-arylmethylene iminodiacentates or n, n'-diarylmethylene ethylenediaminacetates for use in combatting oxidative stress |
| 05/26/1994 | WO1994011027A1 Peripheralization of hematopoietic stem cells |
| 05/26/1994 | WO1994011026A2 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 05/26/1994 | WO1994011023A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 05/26/1994 | WO1994011020A1 Eck receptor ligands |
| 05/26/1994 | WO1994011010A2 Compositions of oak bark extract, related synthetic compositions, and method of using same |
| 05/26/1994 | WO1994011006A1 Compositions for the regulation of cytokine activity |
| 05/26/1994 | WO1994010997A1 Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them |
| 05/26/1994 | WO1994010996A1 Butenyl-substituted taxanes and composition |
| 05/26/1994 | WO1994010995A1 Antitumour compositions containing taxane derivatives |
| 05/26/1994 | WO1994010990A1 Inhibition of tnf production |
| 05/26/1994 | WO1994006909A3 A method of preventing tumor metastasis |
| 05/26/1994 | CA2626445A1 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 05/26/1994 | CA2149431A1 Use of n-arylmethylene ethylenediamine-triacetates, n-arylmethylene iminodiacetates or n,n'-diarylmethylene ethylenediaminacetates against oxidizing stress |
| 05/26/1994 | CA2149309A1 Heat shock proteins and the treatment of tumours |
| 05/26/1994 | CA2149240A1 Process for preparing taxane derivatives; new taxanes thus produced and antitumoral and antileukemia compositions containing the same |
| 05/26/1994 | CA2149205A1 Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides |
| 05/26/1994 | CA2149116A1 Compositions for the regulation of cytokine activity |
| 05/26/1994 | CA2148819A1 Water soluble camptothecin derivatives |
| 05/26/1994 | CA2147859A1 Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them |
| 05/25/1994 | EP0597968A1 New leukotriene-b 4? antagonists, methods of preparing them and their use as drugs |
| 05/25/1994 | EP0597845A1 GROWTH FACTOR WHICH INHIBITS THE GROWTH OF CELLS OVEREXPRESSING THE HUMAN ONCOGENE erbB-2 |
| 05/25/1994 | EP0597844A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
| 05/25/1994 | EP0597829A1 Novel monoclonal antibody to novel antigen associated with human tumors |
| 05/25/1994 | EP0358660B1 Synthetic inhibitors of mammalian collagenase |
| 05/25/1994 | EP0249629B1 Methods and materials for alleviation of pain symptoms of malignant neoplasia |
| 05/25/1994 | CN1087080A Benzenealkanoic acids for cardiovascular diseases |
| 05/25/1994 | CN1024663C Process for preparing substituted tetralins and related compounds in treatment of asthma |
| 05/24/1994 | US5314995 Antitumor |
| 05/24/1994 | US5314911 Antitumor, fungicide |
| 05/24/1994 | US5314908 Compounds useful as antiproliferative agents |
| 05/24/1994 | US5314905 Antitumor |
| 05/24/1994 | US5314889 Hormone antagonists |
| 05/24/1994 | US5314688 Local delivery of dipyridamole for the treatment of proliferative diseases |
| 05/24/1994 | CA1329770C 17-methylene- and 17-ethylidene-estratrienes |
| 05/19/1994 | DE4238778A1 Vektor zur Expression von therapeutisch relevanten Genen Vector for Expression of therapeutically relevant genes |
| 05/19/1994 | DE4238416A1 Bestimmung von Peptidmotiven auf MHC-Molekülen Determination of peptide motifs on MHC molecules |
| 05/19/1994 | CA2103203A1 Pharmaceutical compounds |
| 05/18/1994 | EP0597503A2 ECK receptor ligands |
| 05/18/1994 | EP0597088A1 Novel imidazole derivatives, their preparation and therapeutic applications |
| 05/18/1994 | EP0597018A1 Novel glycoside compounds and production and use thereof |
| 05/18/1994 | EP0316429B1 Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation |
| 05/18/1994 | CN1086815A 2-(1-hydroxyethyl)-5-hydroxynaphthoÛ2,3-BÙfuran-4, 9-dione and antitumor agents comprising this compound |